REQUEST A DEMO
Total
USD $0.00
Search more companies

Alde Medi Impex Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Alde Medi Impex Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alde Medi Impex Limited is an unlisted company, incorporated on 05/03/1997. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24231DL1997PLC085614 and registration number is 085614. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Unit No- 1076, 10Th Floor, Agarwal Millanium Tower-Ii, Netaji Subhash Place, Wazir Pur
North West Delhi; Delhi; Postal Code: 110034

Contact Details: Purchase the Alde Medi Impex Limited report to view the information.

Basic Information
Total Employees:
Purchase the Alde Medi Impex Limited report to view the information.
Outstanding Shares:
Purchase the Alde Medi Impex Limited report to view the information.
Registered Capital:
Purchase the Alde Medi Impex Limited report to view the information.
Incorporation Date:
March 05, 1997
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
19.15%
Purchase this report to view the information.
18.15%
Purchase this report to view the information.
17.1%
Company Performance
Financial values in the chart are available after Alde Medi Impex Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
34.72%
Total operating revenue
36.17%
Operating profit (EBIT)
122.77%
EBITDA
76.67%
Net Profit (Loss) for the Period
120.06%
Total assets
26.42%
Total equity
31.83%
Operating Profit Margin (ROS)
2.52%
Net Profit Margin
1.77%
Return on Equity (ROE)
9.68%
Debt to Equity Ratio
0.89%
Quick Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?